Med Tech & Digital Health
enVVeno Medical Corporation became a LifeSci Advisors client in 2021. The teams collaborated to develop and execute a robust, best-in-class investor relations program to engage the investment community and showcase enVVenos developments. PROCESS This event featured a live virtual presentation featuring two principal investigators from the ongoing VenoValve U.S. pivotal trial: Dr. David Dexter, Sentara…
Read More
InspireMD successfully completed a transformational Private Placement for up to $113.6 million, with $42.2 million financing upfront with up to an additional $71.4 million tied to exercise of milestone-driven warrants. LIFESCI’s ACTIVITIES Continuous efforts to strengthen company relationships with relevant sell-side analysts to improve research coverage through leveraging existing relationships and making new introductions to…
Read More
Orchestra BioMed’s partnership-enabled business model focuses on forging strategic collaborations with leading medical device companies to drive successful global commercialization of products it develops. LIFESCI’s ACTIVITIES LifeSci engaged following a global strategic partnership with Terumo announced in June 2019 Strengthen the equity story and position the Company to secure additional strategic global partnerships Raise visibility…
Read More
Inspire Medical became a LifeSci Advisors client pre-IPO. The teams collaborated to develop and execute a robust, best-in-class investor relations program to engage the investment community The Process A successful strategically timed KOL event before going live on the IPO was well attended by investors and sell-side analysts, attracting potential investors new to the story…
Read More